JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area ubiquitination proteasome ubiquitination'

Search results for: 'research area ubiquitination proteasome ubiquitination'

A3023 P005091

1 Citation

Target: Ubiquitin-specific proteases

Summary: Ubiquitin-specific protease 7 (USP7) inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.4 mg/mL
A8353 3-Methyladenine

3 Citation

Target: PI3K

Summary: Class III PI3K inhibitor

≥5 mg/mL
A8487 Nocodazole

1 Citation

Target: Microtubules/Tubulins

Summary: Tubulin production inhibitor,anti-neoplastic agent

insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
A8628 Chloroquine diphosphate

1 Citation

Target: Autophagy

Summary: Antimalarial drug,TLR7 TLR9 inhibitor

insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL
A4083 Rocilinostat (ACY-1215)

1 Citation

Target: Histone Deacetylases (HDACs)

Summary: Selective HDAC6 inhibitor

≥21.675 mg/mL
A4393 Paclitaxel (Taxol)

4 Citation

Target: Microtubules/Tubulins

Summary: Antineoplastic agent

≥85.6 mg/mL
A8250 LY 294002

16 Citation

Target: PI3K

Summary: Potent PI3K inhibitor
A4010 Salinosporamide A (NPI-0052, Marizomib)

Target: Proteasome

Summary: 20S proteasome inhibitor

Soluble in DMSO
A1933 Carfilzomib (PR-171)

10 Citation

Target: Proteasome

Summary: Proteasome inhibitor, epoxomicin analog

≥35.99 mg/mL
A2614 Bortezomib (PS-341)

24 Citation

Target: Proteasome

Summary: Proteasome Inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL